Long-acting β2-agonist (LABA) and corticosteroid combination inhalers are now very widely used as a twice-daily therapy for asthma and chronic obstructive pulmonary disease (COPD) patients. The onc...
No takes yet. Share an insight, caveat, or question.
Peter J. Barnes (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: